Gross-Zimmern, Germany

Ralf Knierieme



Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Groβ-Zimmern, DE (2009)
  • Gross-Zimmern, DE (2006 - 2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ralf Knierieme: A Pioneer in Medicinal Chemistry

Introduction

Ralf Knierieme, based in Gross-Zimmern, Germany, is an esteemed inventor known for his contributions to medicinal chemistry. With three patents to his name, Ralf has demonstrated a remarkable ability to innovate in complex scientific fields.

Latest Patents

Among Ralf's latest patents is a notable invention concerning the crystal form B of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazin-1-yl]methanone, hydrochloride. This invention addresses the creation of a previously unknown crystal form, along with methods for its preparation and its application for developing medicaments. Additionally, he has developed a process for the preparation of nicotinaldehydes through the reduction of corresponding nicotinic acid morpholinamides. These innovations represent significant advancements in pharmaceutical science.

Career Highlights

Ralf is currently affiliated with Merck Patent GmbH, where he utilizes his expertise to further the company's mission in developing cutting-edge medicinal solutions. His work at Merck exemplifies dedication to innovation in the pharmaceutical industry, contributing to the development of vital therapeutic compounds.

Collaborations

Throughout his career, Ralf has collaborated with distinguished colleagues, including Heinz-Hermann Bokel and Ludwig Gantzert. These collaborations have played a pivotal role in the successful development of his patented inventions, showcasing the importance of teamwork in scientific research.

Conclusion

Ralf Knierieme stands out as a prominent inventor in the field of medicinal chemistry. His patents not only underline his innovative thinking but also contribute significantly to the advancement of healthcare solutions. As he continues to work with inspiring colleagues at Merck Patent GmbH, Ralf's contributions will undoubtedly impact the pharmaceutical landscape for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…